GlassScriptPhysician profile
Matthew Erbst
NPI 1689317083
$1,516.91
in general payments reported to CMS, 2019-2025
10 companies · $795 in 2025
The $795 reported for 2025 was more than what 85% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $156 · 2024: $565 · 2025: $795.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,516.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $342.60 | 2024-2025 | Mako, Simpliciti, Aequalis Ascend Flex |
| Depuy Synthes Sales INC. | $281.16 | 2024-2025 | Na, Tfn-Advance, Dynacord |
| Kuros Biosciences USA, INC | $154.49 | 2025 | Magnetos |
| Heron Therapeutics, INC. | $124.74 | 2024 | Zynrelef |
| Vertex Pharmaceuticals Incorporated | $124.74 | 2025 | |
| Convatec INC. | $124.27 | 2023 | |
| Orthofix Medical, INC. | $101.72 | 2025 | Physio-Stim |
| Pinnacle, INC | $93.10 | 2023-2024 | |
| Polynovo North America LLC | $87.84 | 2024 | Novosorb Btm |
| Si-Bone, INC. | $82.25 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Erbst listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.